A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Clinical trial NCT04873362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04873362
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2028-08-31
- Enrollment
- 1188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.